NPI: 1063646446 · YUBA CITY, CA 95991 · Clinical Medical Laboratory · NPI assigned 05/13/2009
Authorized official LOPES, KRISTA controls 20+ related entities in our dataset. Read more
| Authorized Official | LOPES, KRISTA (SH VP, QUALITY, SAFETY AND PATIENT) |
| Parent Organization | SUTTER MEDICAL FOUNDATION |
| NPI Enumeration Date | 05/13/2009 |
Other providers sharing the same authorized official: LOPES, KRISTA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,244 | $168K |
| 2019 | 8,355 | $139K |
| 2020 | 13,303 | $213K |
| 2021 | 19,300 | $395K |
| 2022 | 22,240 | $552K |
| 2023 | 24,527 | $512K |
| 2024 | 15,070 | $468K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 80081 | 3,555 | 3,363 | $385K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 755 | 755 | $252K |
| 80053 | Comprehensive metabolic panel | 11,646 | 10,704 | $152K |
| 84443 | Thyroid stimulating hormone (TSH) | 6,531 | 6,422 | $143K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 13,652 | 12,434 | $130K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,773 | 1,693 | $118K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,187 | 2,155 | $115K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,111 | 2,081 | $111K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,203 | 1,166 | $110K |
| 83036 | Hemoglobin; glycosylated (A1C) | 8,072 | 7,964 | $110K |
| 80061 | Lipid panel | 5,998 | 5,944 | $103K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 6,682 | 6,307 | $72K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,683 | 1,656 | $62K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 636 | 628 | $60K |
| 84439 | 3,103 | 3,038 | $39K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 472 | 469 | $38K |
| 86803 | 1,489 | 1,465 | $34K | |
| 87081 | 2,977 | 2,956 | $31K | |
| 85027 | 3,293 | 3,215 | $30K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,601 | 2,446 | $27K |
| 82950 | 3,504 | 3,436 | $24K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 529 | 529 | $20K |
| 82951 | 938 | 920 | $17K | |
| 87077 | 1,174 | 1,126 | $16K | |
| 86140 | 2,180 | 1,898 | $15K | |
| 86592 | 2,103 | 2,090 | $14K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 684 | 668 | $14K |
| 87186 | 950 | 915 | $13K | |
| 81001 | 2,891 | 2,735 | $12K | |
| 83540 | 1,308 | 1,279 | $12K | |
| 83550 | 1,068 | 1,057 | $12K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 60 | 57 | $11K |
| 84481 | 382 | 371 | $10K | |
| 86235 | 59 | 59 | $10K | |
| 82728 | 523 | 505 | $10K | |
| 82043 | 1,331 | 1,311 | $9K | |
| 85652 | 2,198 | 1,912 | $8K | |
| 82570 | 1,120 | 1,061 | $7K | |
| 86376 | 287 | 285 | $6K | |
| 83880 | 133 | 124 | $5K | |
| 84702 | 236 | 150 | $5K | |
| 86038 | 249 | 242 | $5K | |
| 87070 | 433 | 425 | $5K | |
| 83690 | 473 | 461 | $5K | |
| 83970 | 79 | 78 | $4K | |
| 82952 | 734 | 721 | $4K | |
| 83001 | 118 | 118 | $4K | |
| 80076 | 393 | 373 | $4K | |
| 81003 | 1,223 | 1,186 | $4K | |
| 82607 | 165 | 164 | $3K | |
| 86160 | 63 | 63 | $3K | |
| 84550 | 554 | 542 | $3K | |
| 82150 | 314 | 296 | $3K | |
| 82746 | 111 | 111 | $3K | |
| 85610 | 573 | 418 | $2K | |
| 84403 | 67 | 67 | $2K | |
| 84153 | 78 | 78 | $2K | |
| 86225 | 61 | 61 | $2K | |
| 87799 | 19 | 19 | $2K | |
| 83735 | 207 | 169 | $2K | |
| 80069 | 162 | 149 | $2K | |
| 80055 | 16 | 16 | $2K | |
| 86431 | 142 | 140 | $1K | |
| 82670 | 27 | 27 | $1K | |
| 83516 | 47 | 47 | $1K | |
| 80074 | 12 | 12 | $903.36 | |
| 87512 | 16 | 16 | $491.20 | |
| 86762 | 29 | 29 | $457.99 | |
| 86364 | 12 | 12 | $324.45 | |
| 85007 | 74 | 74 | $312.09 | |
| 82784 | 24 | 24 | $306.15 | |
| 87205 | 50 | 49 | $238.84 | |
| 87147 | 13 | 13 | $189.76 | |
| 84484 | 14 | 13 | $155.06 | |
| 84460 | 13 | 13 | $153.82 | |
| 84450 | 12 | 12 | $135.90 | |
| 87088 | 15 | 15 | $133.16 | |
| 86850 | 27 | 27 | $115.32 | |
| 84156 | 20 | 17 | $83.22 | |
| 84100 | 16 | 13 | $80.94 | |
| 86901 | 28 | 26 | $74.01 | |
| 81015 | 16 | 16 | $72.96 | |
| 86900 | 25 | 25 | $67.69 | |
| 71045 | Radiologic examination, chest; single view | 412 | 343 | $0.00 |
| 93000 | 254 | 248 | $0.00 | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 298 | 285 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 22 | 22 | $0.00 |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | 672 | 496 | $0.00 |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 153 | 151 | $0.00 |
| 99232 | Subsequent hospital care, per day, moderate complexity | 60 | 31 | $0.00 |
| 76830 | Ultrasound, transvaginal | 12 | 12 | $0.00 |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 166 | 84 | $0.00 |
| 99239 | Hospital discharge day management, more than 30 minutes | 47 | 47 | $0.00 |
| 93320 | 89 | 48 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 16 | 14 | $0.00 |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 89 | 89 | $0.00 |
| 99233 | Prolong inpt eval add15 m | 131 | 62 | $0.00 |
| 93325 | 267 | 139 | $0.00 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 64 | 64 | $0.00 |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 91 | 49 | $0.00 |
| 70450 | Computed tomography, head or brain; without contrast material | 133 | 132 | $0.00 |
| 99223 | Prolong inpt eval add15 m | 41 | 40 | $0.00 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 14 | 14 | $0.00 |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 24 | 24 | $0.00 |
| 71046 | Radiologic examination, chest; 2 views | 146 | 144 | $0.00 |
| 93321 | 23 | 13 | $0.00 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 14 | 14 | $0.00 |